In a new periodic feature, IBO highlights major funding announcements and initiatives that indicate opportunities for instrument and laboratory product makers. Samsung announced in May the formation of the Samsung Future Technology Promotion Foundation, which will invest KRW 1.5 trillion ($900 million = KRW 1.11 =$1) over 10 years in R&D. The Foundation plans to […]
In 2012, R&D spending in US dollars for 21 major publicly held analytical instrument and lab product companies (see table, page 6) increased 6.0% but maintained pace with sales, which grew 6.6%. Given the slower top-line growth compared with 2011 and concerns over research-related spending, R&D initiatives were focused on higher growth biopharmaceutical, clinical and […]
Jena, Germany 5/6/13—Analytik Jena announced that it has purchased all the assets of molecular diagnostics company SIRS-Lab. SIRS-Lab’s offerings were for systemic infections, including LOOXSTER technology for the identification and detection of bacterial and fungal DNA in diagnostic samples. The company filed for bankruptcy in December 2012. Analytik Jena has announced it will place a […]
The first of IBO’s biannual new laboratory roundup focuses on new facilities for cancer treatment and research, along with new genetically modified (GM) crop labs and consumer products labs. In addition, the table on page 6 highlights plans for new labs for the automotive, pharmaceutical and semiconductor industries. Three organizations, including two universities, have announced […]
US R&D grew 1.8% to $414.0 billion in 2011, according to preliminary estimates. But, in constant dollars, the amount, as in the previous two years, is below 2008 levels. Also, as in 2010, R&D grew slower than GDP in 2011. Business funded 60% of US R&D activities in 2011, a 0.1% increase, and performed 69%, […]
Japanese R&D funding increased last fiscal year for the first time in four years. The country’s total R&D spending rose 1.6% in fiscal 2012 (ending March 31, 2012) to ¥17,379 billion ($217.2 billion = ¥80 = $1), according to the annual R&D survey of the Statistics Bureau of Japan’s Ministry of Internal Affairs and Communications. […]
Competitive Pressures Tough government and academic markets and, toward year end, slowing industrial markets, plus lagging global growth, made 2012 a year when instrument and lab product companies had to compete harder than usual in many markets. Many companies noted pricing pressure across product lines, particularly for sales to industrial markets. This effect also played […]
Global R&D spending is forecast to increase 1.8% to $1,496.4 billion in 2013, measured in purchase powered parity, down from 5.2% growth. R&D expenditures in the life sciences, chemicals and energy sectors are expected to increase 4.2%, 0.6% and 1.6% to account for 13%, 3% and 1% of worldwide R&D spending, respectively. R&D spending is […]
According to the latest EU R&D Scoreboard, produced by the EU’s Joint Research Centre, R&D spending by 1,500 of the world’s largest companies grew 7.6% to €510.7 billion ($709.3 billion = €0.72 = $1) in fiscal 2011 (FY11) (results included FY12 information for some companies). In FY10, Scoreboard companies showed a 4.0% increase in R&D […]
Radnor, PA 12/4/12—VWR International has acquired France-based Labonord and Belgium-based Switch for undisclosed amounts. Labonord supplies consumables and chemicals, including histology products. Switch manufactures cytology and histology reagents and dyes under the Q-Path brand, which are sold in France, Belgium and the Netherlands. Labonord is a Switch distributor.
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
